Through a patent-registered, innovative procedure, MAGCELL® ARTHRO is able to create exceptionally strong pulsating magnetic fields of up to 100 mT (1000 gauss) with selective frequency ranges despite its small size. Time-variable magnetic fields can function as transfer media for electric fields. Providing that – like MAGCELL® ARTHRO – the field force is sufficiently high, electro-magnetic fields can be induced in the tissue beyond the internationally recognised threshold for biological effectiveness. Through the possibility of direct application and the resulting close distance of the magnetic field to the application area, MAGCELL® ARTHRO also ensures minimum loss of magnetic field strength, transporting it deep into the tissue layers (electrode-free electrotherapy). Its battery operation and thus constant readiness enables the execution of a therapy programme through repeated short treatments in contrast to treatments previously only offered in doctor’s surgeries.
MAGCELL® ARTHRO is ideal for painful hip, knee and jaw joint arthritis, Hallux rigidus and valgus and a range of other arthritic conditions. Clinical studies on the complementary use of MAGCELL® ARTHRO for acute knee arthritis (1,2) have shown that amongst others, the following clinical effects can be achieved:
- Significant relief from inflammation pain
- Improvement in joint movement
- Reduction of knee joint circumference
- Significant reduction of WOMAC index
Magnetic field therapy is available in a range of types and appearances. Various forms of therapy do not have sufficient scientific proof of their effectiveness. The MAGCELL® ARTHRO medical product cannot be compared with ‘pulsating signal therapy (PST)’, ‘MultiBioSignal Therapy (MBST)’, ‘Nuclear Magnetic Resonance Therapy’, ‘TENS' or other transmission forms such as magnetic field mats or coils.
MAGCELL® ARTHRO works with therapy parameters investigated in empirical and clinical research. There are no known side effects or intolerance associated with the use of MAGCELL® ARTHRO. Based on a large amount of patient feedback, regular therapy may enable reductions in the dosage of medication, such as non-steroidal anti-rheumatic agents.
1 Hitrov N, Portnov V (2008): MAGCELL® ARTHRO in der Behandlung von Arthrose im Kniegelenk. Die Naturheilkunde 3:25-27.
2 Wuschech H, et al. (2009): Effekte von PEMF bei Patienten mit Arthrose: Ergebnisse einer prospektiven, randomisierten, plazebokontrollierten, doppel-blinden Studie. Publication in progress.